Skip to main content
. 2025 Feb 25;22:35. doi: 10.1186/s12984-025-01583-2

Table 2.

Clinical assessment comparison between the active and Sham tDCS groups after treatment

Active tDCS Sham tDCS p
Changes of PSH-AM -19.80Inline graphic1.91 -6.90Inline graphic1.52 <0.001
Changes of CRS-R 3.50Inline graphic2.01 0.90Inline graphic1.29 <0.001
Reduction ratio of clonazepam (%) 95.63Inline graphic6.12 13.75Inline graphic24.97 <0.001
Reduction ratio of propranolol (%) 100.00Inline graphic0.00 70.00Inline graphic25.13 <0.001